Novel Synergistic Combination of Mitotic Arrest and Promotion of Apoptosis for Treatment of Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Synergistic Combination of Mitotic Arrest and Promotion of Apoptosis for Treatment of Pancreatic Adenocarcinoma

Published:2019-04 Issue:4 Volume:12 Page:683-692
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Duan Zhijian,Chinn Danielle,Tu Mei-Juan,Zhang Qian-Yu,Huynh Jasmine,Chen Justin,Mack Philip,Yu Ai-Ming,Kim Edward J.

Funder

National Institutes of Health

UC Davis Comprehensive Cancer Center Support

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival;Jemal;J Natl Cancer Inst,2017

2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;Journal of clinical oncology : official journal of the American Society of Clinical Oncology,1997

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

5. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer;Molecular Therapy;2024-07

2. AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses;Frontiers in Immunology;2023-09-12

3. The application of pancreatic cancer organoids for novel drug discovery;Expert Opinion on Drug Discovery;2023-03-26

4. Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy;Molecular Biomedicine;2023-02-05

5. Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth;Pancreatology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3